Amoéba progresses towards the commercialization of Axpera in 2026

Amoéba, a greentech company based in Chassieu, has announced positive results for its Axpera product, used against mildew. Trials conducted in several French wine-growing regions have demonstrated significant effectiveness, with some winegrowers reducing their use of copper without loss of efficacy. Axpera offers an alternative in a context of tightening phytosanitary regulations in France.

Amoéba is continuing its regulatory process in the United States, Brazil, and Europe. Although some approvals have been delayed by budgetary constraints, progress is being made in California. In Brazil, additional studies are underway. In Europe, the process is well underway, with results expected in early 2026.